Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Array BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Array BioPharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Array BioPharma Acquires Encorafenib from Novartis Pharma 13
Venture Financing 15
Loxo Oncology Raises US$10 Million In Venture Financing 15
Partnerships 16
Array BioPharma Enters into Agreement with Pfizer 16
Amgen and Array BioPharma Enter into Agreement 17
Array BioPharma and Bristol-Myers Squibb Enter into Research Agreement 18
Array BioPharma Enters into Agreement with Merck 19
Dana-Farber Cancer Institute Enters into Research Agreement with Array BioPharma 20
Pierre Fabre Enters into Co-Development Agreement with Array BioPharma 21
Array BioPharma Enters into Drug Discovery Agreement with Biogen Idec 22
Array BioPharma Enters Into Drug Discovery Agreement With Global Blood Therapeutics 23
Clovis Oncology Enters Into Co-Development Agreement With Array BioPharma 24
Licensing Agreements 25
Aslan Pharma Enters into Licensing Agreement with Array BioPharma 25
Ono Pharma Enters into Licensing Agreement with Array BioPharma 26
Mirati Therapeutics Exercises Option For Licensing Agreement With Array BioPharma 27
Asahi Kasei Pharma Enters into Licensing Agreement with Array BioPharma 28
Oncothyreon Enters into Licensing Agreement with Array BioPharma for ONT-380 29
Loxo Oncology Amends Licensing Agreement With Array BioPharma 30
Equity Offering 32
Array Biopharma Plans to Raise up to USD125 Million in Public Offering of Shares 32
Yarra Therapeutics Spins Out from Array BioPharma 33
Array BioPharma Raises USD258.7 Million in Public Offering of Shares 34
Array BioPharma Raises USD132.3 Million in Public Offering of Shares 36
Array Biopharma Announces Public Offering Of Shares For US$75 Million 38
Array BioPharma Completes Underwriters’ Exercise Of Over-Allotment Option For US$10 Million 39
Array BioPharma Completes Public Offering Of Common Stock For US$60 Million 41
Debt Offering 43
Array BioPharma Raises USD10 Million in Private Placement of 5% Notes Due 2017 43
Array BioPharma Completes Public Offering Of Notes Due 2020 For US$132 Million 44
Asset Transactions 46
Accuratus Lab Services Acquires CMC Operation from Array BioPharma 46
Array BioPharma Inc – Key Competitors 47
Array BioPharma Inc – Key Employees 48
Array BioPharma Inc – Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Recent Developments 50
Financial Announcements 50
Oct 30, 2018: Array BioPharma reports financial results for the first quarter of fiscal 2019 50
Aug 14, 2018: Array Biopharma reports financial results for the fourth quarter and full year of fiscal 2018 52
May 09, 2018: Array BioPharma Reports Financial Results For The Third Quarter of Fiscal 2018 56
Feb 06, 2018: Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2018 59
Oct 31, 2017: Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2018 61
Aug 09, 2017: Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017 64
May 10, 2017: Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2017 68
Feb 09, 2017: Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2017 70
Corporate Communications 74
Apr 27, 2017: Shalini Sharp Joins Array BioPharma Board of Directors 74
Legal and Regulatory 75
Nov 21, 2017: Array Biopharma Lead Plaintiff Deadline Alert: Faruqi & Faruqi Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm 75
Product News 76
07/26/2018: Pierre Fabre Medicament receives CHMP’s positive opinion for Braftovi 76
Appendix 77
Methodology 77
About GlobalData 77
Contact Us 77
Disclaimer 77
Array BioPharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Array BioPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Array BioPharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Array BioPharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Array BioPharma Acquires Encorafenib from Novartis Pharma 13
Loxo Oncology Raises US$10 Million In Venture Financing 15
Array BioPharma Enters into Agreement with Pfizer 16
Amgen and Array BioPharma Enter into Agreement 17
Array BioPharma and Bristol-Myers Squibb Enter into Research Agreement 18
Array BioPharma Enters into Agreement with Merck 19
Dana-Farber Cancer Institute Enters into Research Agreement with Array BioPharma 20
Pierre Fabre Enters into Co-Development Agreement with Array BioPharma 21
Array BioPharma Enters into Drug Discovery Agreement with Biogen Idec 22
Array BioPharma Enters Into Drug Discovery Agreement With Global Blood Therapeutics 23
Clovis Oncology Enters Into Co-Development Agreement With Array BioPharma 24
Aslan Pharma Enters into Licensing Agreement with Array BioPharma 25
Ono Pharma Enters into Licensing Agreement with Array BioPharma 26
Mirati Therapeutics Exercises Option For Licensing Agreement With Array BioPharma 27
Asahi Kasei Pharma Enters into Licensing Agreement with Array BioPharma 28
Oncothyreon Enters into Licensing Agreement with Array BioPharma for ONT-380 29
Loxo Oncology Amends Licensing Agreement With Array BioPharma 30
Array Biopharma Plans to Raise up to USD125 Million in Public Offering of Shares 32
Yarra Therapeutics Spins Out from Array BioPharma 33
Array BioPharma Raises USD258.7 Million in Public Offering of Shares 34
Array BioPharma Raises USD132.3 Million in Public Offering of Shares 36
Array Biopharma Announces Public Offering Of Shares For US$75 Million 38
Array BioPharma Completes Underwriters' Exercise Of Over-Allotment Option For US$10 Million 39
Array BioPharma Completes Public Offering Of Common Stock For US$60 Million 41
Array BioPharma Raises USD10 Million in Private Placement of 5% Notes Due 2017 43
Array BioPharma Completes Public Offering Of Notes Due 2020 For US$132 Million 44
Accuratus Lab Services Acquires CMC Operation from Array BioPharma 46
Array BioPharma Inc, Key Competitors 47
Array BioPharma Inc, Key Employees 48
Array BioPharma Inc, Other Locations 49
List of Figures
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Array BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Array BioPharma Inc, Medical Devices Deals, 2012 to YTD 2018 10